Erectile dysfunction can be reversed without medication
By sciencedaily.com
Men suffering from sexual dysfunction can be successful at reversing their problem, by focusing on lifestyle factors and not just relying on medication, according to research at the University of Adelaide.
In a new paper published in the Journal of Sexual Medicine, researchers highlight the incidence of erectile dysfunction and lack of sexual desire among Australian men aged 35-80 years.
"Sexual relations are not only an important part of people's wellbeing. From a clinical point of view, the inability of some men to perform sexually can also be linked to a range of other health problems, many of which can be debilitating or potentially fatal," says Professor Gary Wittert, Head of the Discipline of Medicine at the University of Adelaide and Director of the University's Freemasons Foundation Centre for Men's Health.
"Our study saw a large proportion of men suffering from some form of erectile dysfunction, which is a concern. The major risk factors for this are typically physical conditions rather than psychological ones, such as being overweight or obese, a higher level of alcohol intake, having sleeping difficulties or obstructive sleep apnoea, and age.
"The good news is, our study also found that a large proportion of men were naturally overcoming erectile dysfunction issues. The remission rate of those with erectile dysfunction was 29%, which is very high. This shows that many of these factors affecting men are modifiable, offering them an opportunity to do something about their condition," Professor Wittert says.
The lead author of the paper, Dr Sean Martin from the University of Adelaide's Freemasons Foundation Centre for Men's Health, says: "Even when medication to help with erectile function is required, it is likely to be considerably more effective if lifestyle factors are also addressed.
"This is not only likely to improve their sexual ability, but will be improve their cardiovascular health and reduce the risk of developing diabetes if they don't already have it."
Source: https://www.sciencedaily.com/releases/2014/03/140328102907.htm
Thursday, May 14, 2026
Phenytoin (Dilantin) - Seizures - Patient guide
Phenytoin affordability can be deceptive because the tablet price is only one part of the total treatment cost. Monitoring labs, clinic follow-up, and occasional interaction management all influence long-term expense. Generic phenytoin products are generally available and often inexpensive at baseline, but monthly totals still vary across pharmacies and insurance plans. Different dosage forms, including chewable tablets, capsules, and suspension, may have distinct pricing and coverage rules. Patients should compare final prices at multiple pharmacies, especially when prescriptions are renewed after insurance changes. Mail-order options can reduce cost for stable chronic dosing, but timing must be coordinated carefully to prevent gaps. Insurance formularies may require specific manufacturers or quantity limits. Some plans cover one strength more favorably than another, so prescribers may be able to redesign tablet combinations without changing the intended daily dose. Any change should be clearly explained to avoid accidental underdosing. Because phenytoin has narrow dosing flexibility, running out of medication can quickly become dangerous. Refill requests should be placed early, ideally one week before supply is exhausted, to allow time for prior authorization or stock delays. These practical steps make dilantin-phenytoin pricing options more manageable and reduce adherence-related seizure risk. Patients with frequent travel should ask about early refill allowances and emergency backup plans. Cost conversations should also include lab scheduling. Skipping blood-level checks to save money can lead to larger downstream costs if toxicity or breakthrough seizures occur. Coordinated scheduling of appointments and lab draws can improve both safety and financial predictability. Pharmacists are valuable partners for identifying discount cards, comparing cash versus insurance pricing, and confirming bioequivalent alternatives when inventory changes occur. Documenting the usual manufacturer can also help maintain consistency across refills. For broader information on epilepsy medication access and treatment planning, patients can review the seizure medication planning resource and bring cost-related concerns to neurology visits before adherence problems begin.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.